-
C2917-.1MG
CORTICOTROPIN RELEASING FACTOR ANTAGONIST
Price: $373.84List Price: $415.38Amino Acid Sequence Asp-Leu-Thr-Phe-His-Leu-Arg-Glu-Met-Leu-Glu-Met-Ala-Lys-Ala-Glu-Gln-Ala-Glu-Gln-Ala-Leu-Asn-Arg-Leu-Leu-Glu-Ala-NH2 Biochem/physiol Actions The corticotropin releasing factor (CRF) antagonist α-helical CRF [9-41] exhibits -
213400-1KG
Coumarin, 98% 1kg
Price: $430.33List Price: $478.14CAS: 91-64-5 EC No: 202-086-7 MDL No: MFCD00006850 RTECS: GN4200000 UN No: UN2811 Haz Class: 6.1 Packing Group: III Flakes Molecular Formula: C<sub>9</sub>H<sub>6</sub>O<sub>2</sub> MW: 146.14 Melting Point: 68-73° Boiling Point: 298° -
213400-5KG
Coumarin, 98% 5kg
Price: $1,317.35List Price: $1,463.73CAS: 91-64-5 EC No: 202-086-7 MDL No: MFCD00006850 RTECS: GN4200000 UN No: UN2811 Haz Class: 6.1 Packing Group: III Flakes Molecular Formula: C<sub>9</sub>H<sub>6</sub>O<sub>2</sub> MW: 146.14 Melting Point: 68-73° Boiling Point: 298° -
C656283-1ml
Coumberone (C007B-343818)
Price: $427.70List Price: $475.22Coumberone is a metabolic fluorogenic probe, and isoform-selective substrate for all AKR1C isoforms. Coumberone can be reduced by all four members of the AKR1C family to its fluorescent alcohol coumberol. Coumberone can be used for the research of -
F758508-5mg
Fluorescein Chondroitin sulfate sodium salt
Price: $811.09List Price: $901.22Chondroitin Sulfate (CS) is a type of sulfated GAGs composed of disaccharide units (GlcUA β 1-3GalNAc) composed of glucuronic acid (GlcUA) and N-acetylgalactosamine (GalNAc), which are repeatedly linked by β -1,4-glycosidic bonds. In the process of -
A10040-25.0
n-Acetyl-L-cysteine, 25g (C003B-138790)
Price: $96.04List Price: $106.72Increases cellular pools of free radical scavenger Prevents apoptotic death of neuronal cells Induces apoptosis in human and rat smooth muscle cells Pyrogen free -
A02133-100
SARS-CoV-2 ADE-Causing Antibody (S9HC),100ug
Price: $764.98List Price: $849.98SARS-CoV-2 ADE-causing antibody is a SARS-CoV-2 Spike protein antibody that can exacerbate the COVID-19 disease severity of patients. Antibody-dependent enhancement (ADE) may be involved in the clinical observation of patients with increased